오라팜
Probiotics For Oral Health? Our Probiotics For Oral Health R&D Center Research Papers

OraPharm Oral Probiotics
of Marvelous Efficacy
Determined by 27 Studies

OraPharm conducted multiple clinical trials with the probiotics and
published our research articles in Korean and foreign academic journals.
OraPharm continues researching.

Papers Published by OraPharm

Title

[Paper #24 published by OraPharm]

Writer 오라팜(ip:)

Write date 2021-02-05

Inquiry 16

GPA 0점  

Recommendation Recommend

Content

[Paper #24 published by OraPharm]

Inhibitory effect of the probiotic bacteria, Weissella cibaria CMU on Halitosis: a randomized placebo-controlled study




Source : J Korean Acad Oral Health 2020;44(4):246-252.  / KCI / Clinical Trial

Authors : Da-Hui Kim , Mi-Sun Kang , Ji-Eun Yeu , Myung-Gu Lee , Ja-Won Cho 


Conclusions 

VSC concentrations and sensory evaluation scores were lower in the experimental group than in the control group, but only the latter was statistically significant. Thus, we conclude that W. cibaria CMU is involved in the reduction of halitosis. 



Attached file 논문_24.png

Password
Modify

Please modify or delete the password after entering it.

List
Write answers

orapharm logo오라팜

Business Name:
ORAPHARM Inc.
President:
Yoon Eun-Seop

Business Registration Number:
120-88-17614
Address:
905, Bluestone Tower, 9-16, Yeonmujang 5-gil, Seongdong-gu, Seoul, Republic of Korea
Fax:
02-2054-0154
Mail Order Sales Registration Number:
2018-SEOULSEONGDONG-0614
[View Business Information]
The Person in Charge of Personal Data Privacy:
Lee Tae-Woo
Email:
ora2014@orapharm.com
Business Bank Account:
[Bank – KEB Hana Bank],
[Account Number –
134-910017-81404]
[Account Name:
ORAPHARM Inc.]
Main Telephone Number
1644-3914
Office Hours : 9 a.m. to 6 p.m.
on weekdays
Lunch Break : 12:30 p.m. to 2:00 p.m.
(weekends and holidays off)

©ORAPHARM. All Rights Reserved.

WORLD SHIPPING

PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :

GO
닫기